today announced that the U.S. Food and Drug Administration (“FDA”) has granted Fast Track designation to the BRTX-100 program for the treatment chronic lumbar disc disease (“cLDD”).

Medically reviewed by Mallory Christopherson, DC You may be able to prevent degenerative disc disease (DDD), or limit its ...

A more detailed follow up study should be considered to investigate which particular training activities have the most impact on the lumbar spine, and how to modify training methods so as to avoid the ...

Discectomy with cervical fusion can often help relieve the pain of spinal disc disease. The only caveat is that after the surgery, many people find that they lose some degree of movement in their ...

Other types of back injuries include fracture/compression fractures, degenerative disc disease, disc herniation, radiculopathy, spondylolysis, spondylolisthesis, strain, facet arthritis ...

BioRestorative Therapies, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its BRTX-100 program for treating chronic lumbar disc disease (cLDD).

We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. • Metabolic Program (ThermoStem ®): We are developing cell-based ...